IOL CHEM AND PHARMA LTD (IOLCP)

NSE: ₹136.16
BSE: ₹136.30
Stock Performance
Corporate Announcements
Communication To Shareholders Relating To Unclaimed Dividend

Intimation regarding communication to shareholders relating to unclaimed dividend

2026-06-11 16:28:19
Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-06-10 17:54:11
2026-05-28 16:47:54
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Outcome

Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 FY2026

2026-05-22 17:58:34
2026-05-22 17:48:30
2026-05-21 17:56:19
2026-05-21 16:55:27
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release: Financial Results for the quarter and year ended 31st March 2026

2026-05-20 18:37:35
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report

2026-05-20 18:34:45
Comments Of Board Of Directors

Comments of Board of Directors

2026-05-20 18:32:43

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 563.18 545.30 520.39 503.92 502.38 525.75 523.30 527.78 551.69 567.53 580.39 619.45
YOY Revenue Growth % -0.32% 0.72% -0.59% -14.18% -10.8% -3.59% 0.56% 4.73% 9.82% 7.95% 10.91% 17.37%
Other Income 7.06 7.11 8.38 7.52 7.38 6.43 4.07 4.53 7.37 6.88 5.29 1.84
Total Income 570.24 552.41 528.77 511.44 509.76 532.18 527.37 532.31 559.06 574.41 585.68 621.29
Total Expenses + 509.06 501.23 496.68 474.24 470.24 506.24 499.57 487.61 513.55 533.92 546.92 550.48
Cost of Materials Consumed 376.70 350.99 358.06 349.30 323.02 351.75 335.96 347.61 376.55 366.70 356.70 401.66
Employee Benefit Expense 54.09 48.99 48.29 49.65 53.05 58.70 52.43 52.39 57.65 63.35 56.93 70.33
Other Expenses 71.61 78.59 71.80 82.23 61.85 69.84 69.95 66.85 67.67 78.93 83.74 84.39
Operating Profit 54.12 44.07 23.71 29.68 32.14 19.51 23.73 40.17 38.14 33.61 33.47 68.97
OPM % 9.6% 8.1% 4.6% 5.9% 6.4% 3.7% 4.5% 7.6% 6.9% 5.9% 5.8% 11.1%
Profit Before Tax + 61.18 51.18 32.09 37.20 39.52 25.94 27.80 44.70 45.51 40.49 27.55 70.81
Tax Expense 15.32 13.31 9.01 9.58 9.55 6.79 7.27 13.28 11.58 10.52 6.97 17.65
Tax % 25% 26% 28.1% 25.8% 24.2% 26.2% 26.2% 29.7% 25.4% 26% 25.3% 24.9%
Profit After Tax 45.86 37.87 23.08 27.62 29.97 19.15 20.53 31.42 33.93 29.97 20.58 53.16
EPS (Basic) 7.81 6.45 3.93 4.71 5.11 3.26 3.50 1.07 1.16 1.02 0.70 1.81

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 2,319.06 2,079.21 2,132.79 2,217.11 2,184.02
YOY Revenue Growth % 11.54% -2.51% -3.8% 1.52% -
Other Income 21.38 22.41 30.07 25.61 32.04
Total Income 2,340.44 2,101.62 2,162.86 2,242.72 2,216.06
Total Expenses + 2,144.87 1,963.66 1,981.21 2,054.07 1,977.28
Cost of Materials Consumed 1,501.61 1,358.34 1,435.05 1,536.07 1,578.91
Employee Benefit Expense 248.26 216.57 201.02 168.21 141.30
Other Expenses 314.73 268.49 304.23 276.14 213.92
Operating Profit 174.19 115.55 151.58 163.04 206.74
OPM % 7.5% 5.6% 7.1% 7.4% 9.5%
Profit Before Exceptional 195.57 137.96 181.65 188.65 238.78
Exceptional Items -11.21 0.00 0.00 0.00 -13.93
Profit Before Tax + 184.36 137.96 181.65 188.65 224.85
Tax Expense 46.72 36.89 47.22 49.51 57.18
Tax % 25.3% 26.7% 26% 26.2% 25.4%
Profit After Tax 137.64 101.07 134.43 139.14 167.67
EPS (Basic) 4.69 3.44 22.90 23.70 28.56

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 1,359.32 1,230.73 1,124.63 1,101.74 881.48
Property, Plant & Equipment 1,165.38 1,158.37 921.56 751.02 559.49
Capital Work in Progress 93.61 20.81 99.83 81.40 102.03
Non-Current Investments 17.41 17.41 0.00 17.41 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 12.78 12.34 11.57 0.65 0.18
Current Assets + 1,227.63 1,151.34 1,119.77 920.39 1,080.82
Inventories 371.07 360.62 424.84 325.52 409.89
Trade Receivables 603.13 513.69 471.23 505.28 469.80
Cash and Cash Equivalents 65.35 78.17 7.69 1.39 3.56
Current Investments 3.51 3.30 2.88 2.56 2.37
LIABILITIES & EQUITY
Total Equity 1,798.55 1,687.66 1,611.51 1,507.72 1,392.28
Equity Share Capital 58.71 58.71 58.71 58.71 58.71
Other Equity 1,739.84 1,628.95 1,552.80 1,449.01 1,333.57
Non-Current Liabilities 98.22 84.50 72.89 58.15 56.62
Current Liabilities 690.18 609.91 560.00 456.26 513.40
Total Liabilities 788.40 694.41 632.89 514.41 570.02

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 214.32 178.62 290.08 122.27 93.05
Cash from Investing Activities -198.11 -154.18 -191.28 -120.00 -120.19
Cash from Financing Activities -29.03 46.04 -92.50 -4.11 -1.64
Net Increase/Decrease in Cash -12.82 70.48 6.30 -1.84 -28.78